NEOADJUVANT THERAPY-INDUCED SARCOPENIA IS ASSOCIATED WITH DECREASED OVERALL SURVIVAL IN PANCREATIC DUCTAL ADENOCARCINOMA

被引：0
|
作者：
Sell, Naomi M.
Fernandez-del Castillo, Carlos
Ferrone, Cristina R.
Lillemoe, Keith
Hank, Thomas P.
Weekes, Colin D.
Torriani, Martin
Buckless, Colleen G.
Silver, Julie K.
Fintelmann, Florian J.
Qadan, Motaz
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
795
引用
收藏
页码：S1527 / S1528
页数：2
相关论文
共 50 条
  • [1] Evaluation of Pathologic Response on Overall Survival After Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma
    Sell, Naomi M.
    Lee, Grace C.
    Fernandez-Del Castillo, Carlos
    Ferrone, Cristina R.
    Warshaw, Andrew L.
    Hong, Theodore S.
    Blaszkowsky, Lawrence S.
    Lillemoe, Keith D.
    Qadan, Motaz
    [J]. PANCREAS, 2020, 49 (07) : 897 - 903
  • [2] Total neoadjuvant therapy is associated with improved overall survival and pathologic response in pancreatic adenocarcinoma
    Villano, Anthony M.
    O'Halloran, Eileen
    Goel, Neha
    Ruth, Karen
    Barrak, Dany
    Lefton, Max
    Reddy, Sanjay S.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2022, 126 (03) : 502 - 512
  • [3] Morphometric Assessment of Neoadjuvant Therapy-Induced Tumor Microenvironment Remodeling and Its Prognostic Implications in Pancreatic Ductal Adenocarcinoma
    Li, Danting
    Kalyan, Sonu
    Zhao, Chaohui
    Liu, Yaozhong
    Liu, Yongjun
    Zhang, Xiaofei
    [J]. LABORATORY INVESTIGATION, 2024, 104 (03) : S1842 - S1843
  • [4] Neoadjuvant therapy for localized pancreatic ductal adenocarcinoma
    Brown, Zachary J.
    Shannon, Alexander H.
    Cloyd, Jordan M.
    [J]. MINERVA SURGERY, 2024,
  • [5] Outcomes of Margin Status on Survival in Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Therapy
    Swami, Ashish
    Varshney, Vaibhav Kumar
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 232 (06) : 1022 - 1023
  • [6] Sarcopenia in Patients Undergoing Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Can Surgical Resection Be Predicted?
    Davis, Catherine H.
    Beier, Matthew
    Aslam, Anum
    Grandhi, Miral S.
    Kennedy, Timothy J.
    August, David A.
    Ecker, Brett L.
    Bramwit, Mark
    Langan, Russell C.
    Pitt, Henry A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 237 (05) : S476 - S477
  • [7] Neoadjuvant Therapy Is Associated With Improved Survival in Resectable Pancreatic Adenocarcinoma
    Artinyan, Avo
    Anaya, Daniel A.
    McKenzie, Shaun
    Ellenhorn, Joshua D. I.
    Kim, Joseph
    [J]. CANCER, 2011, 117 (10) : 2044 - 2049
  • [8] Increased SPARC expression is associated with neoadjuvant therapy in resectable pancreatic ductal adenocarcinoma
    Hartley, Christopher
    Rowan, Daniel
    Chen, Xiuxu
    Gomez-Arellano, Luisa
    West, Anna Marie
    Oshima, Kiyoko
    Mackinnon, Alexander Craig
    [J]. PRACTICAL LABORATORY MEDICINE, 2020, 21
  • [9] LYMPH NODE YIELD IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL AND INCREASED TIME TO RECURRENCE IN NODE-NEGATIVE PANCREATIC DUCTAL ADENOCARCINOMA FOLLOWING NEOADJUVANT THERAPY
    Servin-Rojas, Maximiliano
    Fong, Zhi Ven
    Lionetto, Gabriella
    Bolm, Louisa
    Ferrone, Cristina R.
    Castillo, Carlos Fernandez-Del
    Rocha-Castellanos, Dario M.
    Lillemoe, Keith D.
    Qadan, Motaz
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S1512 - S1512
  • [10] Patient Preferences for Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma
    Hamad, Ahmad
    Crossnohere, Norah
    Ejaz, Aslam
    Tsung, Allan
    Pawlik, Timothy M.
    Sarna, Angela
    Santry, Heena
    Wills, Celia
    Cloyd, Jordan M.
    [J]. PANCREAS, 2022, 51 (06) : 657 - 662
12345